  A combination of Lactobacillus<pathogen> acidophilus<pathogen> CL1285 , Lactobacillus<pathogen> casei<pathogen> LBC80R and Lactobacillus<pathogen> rhamnosus<pathogen> CLR2 was compared to placebo for relief of symptoms of irritable bowel syndrome<disease> ( IBS). A total of 113 subjects at 3 clinical sites were randomised in a 2:1 ratio and followed for 12 weeks. Subjects ingested either 2 capsules of active study product , containing 50 Ã— 10